Participants sought: An adjunctive pro-cognitive treatment in schizophrenia

This study by Monash Alfred Psychiatry Research Centre (MAPrc) is being conducted in order to determine if two different doses of EVP-6124 improve mental function and are safe in people who have schizophrenia and are taking another medication for their illness.

Contact: Mr Daniel Grice ph (03) 9076 6581 Email participate.maprc@monash.edu

Website link: http://www.maprc.org.au/psychopharmacology

Ethics Committee Project Number: 110/13